← Back to Search

Ultrasound-Guided Pacemaker Implantation for Slow Heart Rate (RADICAL USE Trial)

N/A
Recruiting
Research Sponsored by Habib Khan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure
Awards & highlights

RADICAL USE Trial Summary

This trial is investigating whether ultrasound can be used to guide the implantation of pacemaker leads into the heart, in order to reduce the amount of radiation exposure for both the patient and the doctor.

Who is the study for?
This trial is for adults over 18 who need a single-chamber pacemaker or cardioverter-defibrillator. It's not suitable for individuals with a BMI over 30, pregnant women, those needing more complex devices, people with claustrophobia, chest wall issues like trauma or radiation treatment history, active cancer patients, or those with certain implants that interfere with ultrasound.Check my eligibility
What is being tested?
The study is testing if using ultrasound instead of radiation can be effective in guiding the implantation of leads into the heart during pacemaker placement. This could potentially reduce risks associated with repeated radiation exposure and allow smaller centers to perform these procedures without expensive X-ray equipment.See study design
What are the potential side effects?
Ultrasound use in this context is generally safe and does not have significant side effects. However, there may be minor discomfort from the pressure of the handheld probe used during echocardiography.

RADICAL USE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Success of implanting a single chamber lead with use of ultrasound
Secondary outcome measures
Duration of radiation will be measured in seconds
Total radiation dose will be collected in centiGray and milliGray units.

RADICAL USE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Reduced fluoroscopy armExperimental Treatment1 Intervention
Patients exposed to 20 seconds or less of fluoroscopy to implant a single chamber device with aid of ultrasound / echocardiography.
Group II: Conventional armActive Control1 Intervention
Patients exposed to more than 20 seconds of fluoroscopy to implant a single chamber device with/without the aid of ultrasound / echocardiography.

Find a Location

Who is running the clinical trial?

Habib KhanLead Sponsor
2 Previous Clinical Trials
304 Total Patients Enrolled

Media Library

Ultrasound / Echocardiography Clinical Trial Eligibility Overview. Trial Name: NCT04858698 — N/A
Slow Heart Rate Research Study Groups: Reduced fluoroscopy arm, Conventional arm
Slow Heart Rate Clinical Trial 2023: Ultrasound / Echocardiography Highlights & Side Effects. Trial Name: NCT04858698 — N/A
Ultrasound / Echocardiography 2023 Treatment Timeline for Medical Study. Trial Name: NCT04858698 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an ongoing recruitment process for this trial?

"Affirmative. Clinicaltrials.gov has published that this medical trial is currently enrolling patients; the initial post date was July 30th 2021 and it just underwent a renewal on October 2nd 2022."

Answered by AI

How many participants are included in this trial?

"Affirmative, the clinicaltrials.gov website shows that this research is currently seeking participants. The initial listing was made on July 30th 2021 and has been amended as recently as October 2nd 2022. In total, 66 individuals are needed to take part in this trial at a single location."

Answered by AI
~4 spots leftby Jun 2024